CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers
about
Cancer stem cells (CSCs), cervical CSCs and targeted therapiesThe Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in CancerAberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerTherapies targeting cancer stem cells: Current trends and future challengesTherapeutic strategies targeting cancer stem cellsCD44 as a potential diagnostic tumor markerData management strategies for multinational large-scale systems biology projectsCD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditionsPhosphatidylinositol 4,5-bisphosphate clusters the cell adhesion molecule CD44 and assembles a specific CD44-Ezrin heterocomplex, as revealed by small angle neutron scatteringA critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistanceBuoyancy-activated cell sorting using targeted biotinylated albumin microbubbles.Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cellsChallenging the roles of CD44 and lipolysis stimulated lipoprotein receptor in conveying Clostridium perfringens iota toxin cytotoxicity in breast cancer.CD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapyHigh throughput identification of monoclonal antibodies to membrane bound and secreted proteins using yeast and phage display.A 41-gene signature derived from breast cancer stem cells as a predictor of survival.The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway.DNA aptamers against exon v10 of CD44 inhibit breast cancer cell migration.Gastric cancer stem cells: evidence, potential markers, and clinical implications.Cell-specific optoporation with near-infrared ultrafast laser and functionalized gold nanoparticles.Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogsISOexpresso: a web-based platform for isoform-level expression analysis in human cancerPYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop.A summary of relationships between alternative splicing and breast cancer.Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal.The role of cancer stem cells in breast cancer initiation and progression: potential cancer stem cell-directed therapies.Targeting MCM2 function as a novel strategy for the treatment of highly malignant breast tumors.Gene expression profiling of circulating tumor cells and peripheral blood mononuclear cells from breast cancer patients.Regulation of CD44 expression and focal adhesion by Golgi phosphatidylinositol 4-phosphate in breast cancer.CD44 receptor unfolding enhances binding by freeing basic amino acids to contact carbohydrate ligand.Comparable roles of CD44v8-10 and CD44s in the development of bone metastases in a mouse model.Glycerophosphoglycerol, Beta-alanine, and pantothenic Acid as metabolic companions of glycolytic activity and cell migration in breast cancer cell lines.Lung-derived factors mediate breast cancer cell migration through CD44 receptor-ligand interactions in a novel ex vivo system for analysis of organ-specific soluble proteins.A novel mechanism of regulating breast cancer cell migration via palmitoylation-dependent alterations in the lipid raft affiliation of CD44.Comprehensive landscape of subtype-specific coding and non-coding RNA transcripts in breast cancer.Monoclonal antibodies against human cancer stem cells.Deregulation of splicing factors and breast cancer development.Stem cells - biological update and cell therapy progress.Alternative Pre-mRNA Splicing in Mammals and Teleost Fish: A Effective Strategy for the Regulation of Immune Responses Against Pathogen Infection.Hyaluronic Acid Nanohydrogel Loaded With Quercetin Alone or in Combination to a Macrolide Derivative of Rapamycin RAD001 (Everolimus) as a New Treatment for Hormone-Responsive Human Breast Cancer.
P2860
Q26747144-A032A9A2-38D8-47F7-8C36-092DFEF56B84Q26747319-0449984C-048C-4B32-BA46-C0C74B17F3D1Q26773907-064A9742-3AE9-4FA0-B850-309AE49EAD06Q26777880-5A8240CF-784B-4F42-B69E-F6BD7D09954CQ26781398-424F0EF7-49CA-4B9A-8C73-DAF9A4674726Q26866085-66D36789-ABE7-4BCC-A15D-799271260082Q27009050-6CE06836-1507-42B4-8666-DBCB96D12315Q28250164-BF36AEBF-CA25-4445-BCEE-EF4DE6668977Q28255119-1F14988E-15A6-4730-85FB-CB7D7420E5FFQ28543175-7CA6AA87-EE82-4170-A3DB-17C1166DB9E8Q30410757-62F85BDD-F3EE-459A-9096-78519C9B1FF9Q33759701-619FFADA-5E7E-4957-8F18-3CB4BBD0AC7DQ33864348-10D3C8BF-3ECB-4A5F-B3AB-7AFCED099067Q33993634-1CC6E3B8-C609-41BE-8332-668FEA3A7CAAQ34421055-0B2804F3-D12F-4C33-A68D-3C00C3D3BA66Q34500627-4B253E7F-AA36-47EB-A559-7368BE5E60EAQ34606294-F47B3C0E-2F27-4830-BE72-AFEBF240C9BDQ35106226-2015E02C-C4E0-450A-BDA6-8E399A8BCB35Q35795934-54400EE7-BD7B-4E52-8B1D-A00689A0D43AQ35804266-02E857CC-9B1F-4530-B044-0DE565D926D2Q35932396-A3B4935D-A7A9-48BA-AE24-9FAE0058E595Q36103082-EADB5BA8-38B2-4FC8-B796-B86ECF06EAD0Q36355925-CC8D2176-1C6E-4D98-872F-85403CC13CB4Q36378283-2DA97099-2512-4954-BE81-D7ABE45CD6D7Q36394240-964485D9-CA57-4D71-9133-FC685878BBD2Q36405638-BF9356B7-6362-43B6-84F7-5BAE4E8272BCQ36544248-66BE4169-F5C9-46C5-B538-73ABBB996461Q36821154-51F2BFEE-7DDB-44C7-84FF-DBD3EF327796Q37098317-26D5C943-3FA1-4666-8C6E-EC6DD27DA796Q37145661-049974D6-4346-410C-A23C-B02ACC11A1B3Q37288727-EA827341-919B-45F1-8619-8B2F7C259C7AQ37608829-C92B7393-D6EF-4418-BEC4-EFBD4346B702Q37689609-CDACC259-6ED1-42A8-9F67-E50362F75BE6Q37690517-B1045A6D-FE1E-47DE-9FD2-8B7047192768Q37708863-FE2BBB2A-F161-400C-ADBE-0491570D7C28Q38206818-3380C855-40C0-4792-9296-4645EB713DBAQ38463397-7D275639-D0E2-4A2E-98EB-712CE1289AF1Q38648343-5F24E91A-B546-410F-A7F4-AE6882148696Q38656528-E642F9DC-A818-47F1-AF58-B52DF13AA999Q38747583-AB7C6117-9FE3-4FE9-A71A-D212C7075403
P2860
CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
CD44 isoforms are heterogeneou ...... s and cancer stem cell markers
@ast
CD44 isoforms are heterogeneou ...... s and cancer stem cell markers
@en
CD44 isoforms are heterogeneou ...... s and cancer stem cell markers
@nl
type
label
CD44 isoforms are heterogeneou ...... s and cancer stem cell markers
@ast
CD44 isoforms are heterogeneou ...... s and cancer stem cell markers
@en
CD44 isoforms are heterogeneou ...... s and cancer stem cell markers
@nl
prefLabel
CD44 isoforms are heterogeneou ...... s and cancer stem cell markers
@ast
CD44 isoforms are heterogeneou ...... s and cancer stem cell markers
@en
CD44 isoforms are heterogeneou ...... s and cancer stem cell markers
@nl
P2093
P2860
P50
P356
P1433
P1476
CD44 isoforms are heterogeneou ...... s and cancer stem cell markers
@en
P2093
Cecilia Hegardt
Dorthe Grabau
Eleonor Olsson
Gabriella Honeth
Göran Jönsson
Karolina Holm
Kristina Lövgren
Mårten Fernö
Pär-Ola Bendahl
P2860
P2888
P356
10.1186/1471-2407-11-418
P407
P577
2011-09-29T00:00:00Z
P5875
P6179
1012446249